Sign in

Research summary ·

Adrenal involvement in antiphospholipid syndrome and SLE-spectrum disease: a systematic review and pooled individual-patient analysis.

Written based on 1 research study on PubMed, searched on 5 Nov 2026.

What was studied

This was a systematic review of published cases. It covered adrenal problems in antiphospholipid syndrome, or APS. It also covered lupus-spectrum disease. The authors split the problems into types. One type was vascular injury of the glands. Another was insufficiency. The last was strict adrenal crisis. They searched up to March 31, 2026. They pooled data from single patients.

What they found

103 studies with 155 patients were included. 143 patients entered the main analysis. Median age was 43.8 years. Bleeding was the leading imaging pattern. Both adrenal glands were often involved. Adrenal insufficiency was the first sign in most informative cases. Low blood pressure was noted in 60 of 125 cases. Strict adrenal crisis was noted in 64 of 124 cases. Low sodium was noted in 47 of 142 cases. High potassium was noted in 57 of 134 cases.

What it means for patients

The authors call adrenal involvement a mixed but recognizable high-risk pattern. They say it often involves both glands and bleeding. They say careful terms help tell these states apart. They say urgent hormone rescue and clot checks still matter.

Why it is not certain yet

This work pooled published patients from 103 studies. Data were not complete for every case. Some counts use only informative cases. The abstract calls the group mixed. The abstract gives no comparison group.

Source

Adrenal involvement in antiphospholipid syndrome and SLE-spectrum disease: a systematic review and pooled individual-patient analysis.

PubMed · PMID 42317308

We restate facts from the source record in our own words. The original wording belongs to its publisher.

This page is not medical advice. Talk to your doctor about your own care.

Back to Lupus (SLE) publications